Therapeutic and palliative options for diffuse neuroendocrine metastatic disease.
Holen
Kyle
K
University of Wisconsin Comprehensive Cancer Center, Madison, WI 53792, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003606:Dacarbazine / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000473:pathology; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007155:Immunologic Factors; D009607:Nitrosourea Compounds; D013004:Somatostatin; D003606:Dacarbazine